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We hypothesized that ozone, a common air pollutant, potent in producing airway inflammation, would increase the
production of exhaled nitric oxide (NO). If so, measurement of exhaled NO could potentially be a valuable tool in
population studies of air pollution effects.
Eleven healthy non-smoking volunteers were exposed to 0?2 ppm ozone (O3) and filtered air for 2 h on two
separate occasions. Exhaled NO and nasal NO were measured before and on five occasions following the exposures.
Changes in exhaled and nasal NO after ozone exposure were adjusted for changes after air exposure.
There was a slight decrease in exhaled NO (70?6; 73?1–1?2 ppb) (median and 95% confidence interval) and of
nasal NO (757; 7173–75 ppb) directly after the ozone exposure. No significant changes in exhaled or nasal NO
were however found 6 or 24 h after the exposure.
Within the examined group, an O3 exposure level proven to induce an airway inflammation caused no significant
changes in exhaled or nasal NO levels. Hence, the current study did not yield support for exhaled NO as a useful
marker of ozone-induced oxidative stress and airway inflammation after a single exposure. This contrasts with data
for workers exposed to repeated high peaks of ozone. The potential for exhaled NO as a marker of oxidative stress
therefore deserves to be further elucidated.
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Nitric oxide (NO) can be detected in exhaled air of healthy
individuals. NO is generated from L-arginine by the enzyme
NO-synthase, of which at least three different iso-forms
exist (1). It has also been proposed that NO could be
formed non-enzymatically during oxidative stress (2, 3).
The main sources of NO production in human airways are
the paranasal sinuses where very high concentrations have
been detected (more than 20 ppm) (4). A low basal level of
NO is also formed in the epithelial cells of the respiratory
tract and this might be further induced by iNOS (inducible,
Ca2+-independent, type II NO synthase) by various
inflammatory cytokines (5). Increased exhaled NO levelsRecevied 28 August 2000 and accepted in revised form 12 March
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asthmatics. Both are down-regulated by inhaled glucocor-
ticoids (6,7). Hence NO in exhaled air has been proposed as
a marker of airway inflammation (8).
Ozone is a major component of urban air pollution. It is
a well-known respiratory irritant causing both nasal and
distal airway inflammation, predominantly involving poly-
morphonuclear leukocytes (PMNs) (9). After ozone
exposure, the PMNs are believed to alter their oxidant-
generating capability in the lung, further contributing to
lung injury (10). Superoxide anion produced by neutrophils
and macrophages might react with NO to form peroxy-
nitrite, an even more potent cytotoxic oxidant (11). Little is
yet known about how ozone interacts with NO formation
in humans and how exhaled NO levels are affected. In rats,
exposure to 2 ppm of ozone has been shown to induce iNOS
expression and NO production in airway type II cells and
macrophages (12,13). Superoxide has been shown to induce
iNOS expression in human epithelial cells in vivo (14).
Further, in iNOS knock-out mice, no peroxynitrite is
formed after ozone exposure and these animals also seem to# 2001 HARCOURT PUBLISHERS LTD
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Hence it has been suggested that NO might be an important
mediator of ozone-induced lung injury. We have previously
found increased NO levels in exhaled air (16) of pulp mill
workers exposed to high peak levels of ozone (1–2 ppm). In
that study, the peak ozone exposure preceded the NO
measurements by months, thus possibly reflecting chronic
inflammatory changes in the airways.
In this study, we aimed to investigate whether measure-
ment of NO in exhaled air could be a useful biomarker for
monitoring the effects of ozone at ambient levels on the
respiratory tract.
Subjects and methods
STUDY SUBJECTS
Eleven healthy non-smoking volunteers (six males and five
females; mean age 24 years, range 20–29 years) without any
history of asthma or other pulmonary diseases, participated
in the study. One subject had a positive skin prick test
against moulds, but no symptoms. The other subjects were
non-atopic. All had normal lung function with a mean
forced expiratory volume in 1 sec (FEV1) of 112% (range
96–137%) (17). None had a history of upper respiratory
tract infection 3 weeks prior to the first exposure or during
the study.
The local ethics committee approved the study and
informed consent was obtained from all volunteers prior to
inclusion in the study.
EXPOSURE
The subjects were exposed twice, once to 0?2 ppm ozone
(O3) and once to filtered air, for 2 h at least 2 weeks apart,
in an exposure chamber, as previously described (18). Half
of the subjects were randomized to first be exposed to
filtered air and the other half were first exposed to ozone.
During the 2-h exposure, mild exercise was alternated with
rest at 15-min intervals. Exercise was performed using a
cycle ergometer situated within the chamber, with a
sucient loading to produce an average minute ventilation
of 20 lmin71m72 body surface area. The exposures were
single-blinded in that the subjects were blinded with regard
to the exposure of either ozone or air.
EXHALED AND NASAL NITRIC OXIDE
NO was measured with a chemiluminescence analyser
(Ecophysics CDL 700AL, Du¨rnten, Switzerland) before
and at 0, 0?5, 1?0, 1?5, 6 and 24 h after exposure. The NO
measurements were performed in accordance with ERS
guidelines (19), as previously described (20). After inhaling
NO-free air the subjects were asked to performed a single
slow exhalation with a constant expiratory flow rate of
0?150 l sec71 against an oral pressure of 10 cm H2O, using
online visual monitoring. The mean NO concentration
(ppb) of exhaled NO (eNO) during the latter part of theexhalation (the plateau-phase) was registered. The mean of
three successive recordings, at an interval of 1min, has been
used in the analysis.
Nasal NO (nNO) was measured by letting the analyser
sample nasal air directly from one nostril. The sampling
probe was connected to a soft polystyrene nasal olive and
gently introduced into the vestibulum of one nostril. The
contralateral nostril was left open. The subjects were
instructed to keep their breath for 20 sec with the soft
palate voluntarily closed, while the analyser sampled nasal
air at a constant rate of 0?06 lmin71 (20). The NO
concentration during the plateau-phase was registered and
the mean of one measurement in each nostril is presented.
Whenever the NO concentration in ambient air exceeded 20
ppb the air concentration of NO was subtracted from the
result.
BLOOD SAMPLES
Peripheral blood samples were drawn prior to the
exposures, after 6 and after 24 h. Analyses of neutrophil
counts were performed with an auto-analyser at the
Department of Clinical Chemistry, University Hospital,
Umea˚, according to clinical routine. For the analyses of
myeloperoxidase (MPO) the blood was allowed to clot for
60–120min, and serum was separated by centrifugation and
kept in freezer (7208C) until analysed. The analyses were
carried out with a commercial radio-immunoassay kit
(Pharmacia Upjohn, Uppsala, Sweden).
STATISTICS
Statistical analyses were carried out with SAS, version 6?12
(SAS Statistical package, Cary, NC, U.S.A). The results
have been given as median exhaled NO concentration (ppb)
(Table 1) and median nasal NO concentration (ppb) (Table
2) after air and ozone exposures respectively. For each
subject, air-adjusted values were calculated as [(after ozone
exposure7before ozone exposure)7(after air exposure7
before air exposure)] at 0, 30min, 60min, 90min, 6 h and
24 h (Tables 1 and 2). Since these values (NO, neutrophils
and MPO) were not normally distributed, the medians and
the 95% confidence intervals (CI) for medians are presented
(21).
Results
The exhaled and nasal NO concentrations after exposure to
air and ozone are shown in Tables 1 and 2. The individual
changes of the ozone-induced effects on exhaled NO (ppb),
adjusted for changes after air exposure at 0, 6 and 24 h are
shown in Fig. 1. When adjusted for filtered air exposure,
there was a slight but non-significant decrease in exhaled
NO concentration (70?3;73?1–1.2 ppb) (median; 95% CI)
and nasal NO (756; 7173–75 ppb) immediately after the
exposure (time 0) (Tables 1 and 2).
In the peripheral blood, the number of neutrophils
increased after ozone exposure (2?0; 1?5–2?5 109 l71), as
TABLE 1. Median exhaled NO concentration (ppb) at
different time points before and after exposures to air and
0?2 ppm ozone. The medians of the differences for each
subject, calculated as [(after ozone exposure7before ozone
exposure)7(after air exposure7before air exposure)], at
each time point are also shown, as well as the 95%
confidence intervals for the difference
Exposure
Time Air Ozone Difference 95% CI
Before 7?7 7?2 — —
After
0 7?8 6?6 70?6 73?1–1?2
30min 7?0 6?5 71?0 72?1–3?9
60min 7?2 7?7 0?5 71?7–4?0
90min 7?2 7?6 0?7 72?6–3?8
6 h 8?8 7?4 0?3 70?5–2?3
24 h 6?8 6?6 70?4 73?0–3?8
TABLE 2. The median nasal NO concentration (ppb) at
different time points before and after exposures to air and
0?2 ppm ozone. The medians of the differences for each
subject, calculated as [(after ozone exposure7before ozone
exposure)7(after air exposure7before air exposure)], at
each time point are also shown, as well as the 95%
confidence intervals for the difference
Exposure
Time Air Ozone Difference 95% CI
Before 444 520 — —
After
0 572 531 756?6 7173–75
30min 566 497 715?0 7198–60
60min 535 507 5?3 7183–114
90min 559 487 9?5 7184–65
6 h 570 554 5?0 7202–65
24 h 494 477 716?5 7221–107
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adjusting for air exposure, the increase in neutrophils after
ozone exposure was not statistically significant (0?5;70?4–
1?4 109 l71). Similarly, MPO increased after both air (30;
733–207 mg l71) and ozone exposure (114; 79–431mg l71)
and when adjusted for the increase after air exposure the
change after ozone exposure was not significant.
Discussion
No major effects of exhaled or nasal NO after experimental
exposure to ozone in ambient levels could be detected inthis study. Exhaled and nasal NO decreased slightly, but
non significantly, directly after exposure. One hour after the
ozone exposure, the nasal and exhaled NO levels were
normalized and remained so for the rest of the follow-up
period. Our hypothesis was however to find an increase in
exhaled NO due to airway inflammation. We have
examined a small number of subjects and there is a
considerable variation of changes in exhaled NO between
subjects, which limits our possibilities to detect small
changes after the ozone exposure. Hypothetically, if we
could assume the changes to be normally distributed, then
the power to detect a 50% increase of exhaled NO would be
99% 6 h after the exposure, when we know from earlier
studies that airway inflammation is present.
We do not believe that lack of internal validity is the
reason for the negative results. NO measurements were
performed with high accuracy according to ERS guidelines
and the results can hardly be biased. It is also dicult to
comprehend how selection bias could influence the results.
Similar results have also recently been published in a study
by Nightingale et al. (22).
There may be different explanations for the lack of effects
on exhaled NO-levels following ozone exposure. Firstly, the
airway inflammation after this relatively low exposure level
might be mild. Even though an increased number of
neutrophils has been described in BAL after exposure to
lower ozone levels (23) it is unknown whether the
neutrophils are activated and really take part in an
inflammatory process or whether they serve a protective
purpose. No increase of myeloperoxidase, a marker for
neutrophilic activation, has been shown in healthy volun-
teers after equivalent exposure (24). The increased NO-
levels we described in pulp mill workers were related to
markedly higher ozone exposure levels, 1–2 ppm (16). In the
same study, we found a significant correlation between eNO
and MPO among never-smokers (unpublished results)
indicating that these workers had activated neutrophils.
Secondly, it could be that an increased production of NO
occurs in the most distal airways and the terminal
bronchioli–alveolar junction, but with the current method
of measuring exhaled NO we were not able to detect it.
Animal studies and mathematical modelling of ozone
uptake show distal airway inflammation, primarily at the
broncho-alveolar junction, to be most likely after ozone
exposure (25,26). The increased levels of exhaled NO
among patients with asthma are, in contrast, believed to
originate in the central airways, and the contribution of NO
from distal parts of the lungs is assumed to be small (27).
This might imply that even if a more distal airway
inflammation were present, we would not have been able
to detect it by the technique for NO measurements used in
this study.
Thirdly, NO is a free radical, which reacts rapidly with
ozone to form peroxynitrite or other reactive oxygen
intermediates. If the produced NO were scavenged in this
way, the levels of NO would decrease in exhaled air. This
might explain the tendency towards decreased eNO directly
after the ozone exposure, although the study size was too
small to detect any significant changes. In a similar way
would superoxide anion, produced by neutrophils, react
FIG. 1. Individual change of exhaled NO (ppb) after ozone exposure, adjusted for changes of exhaled NO after exposure for
filtered air.
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did not find any increase of eNO 6 or 24 h after the
exposure, when we would assume airway neutrophilia to be
present. Animal models have shown an increased formation
of peroxynitrite by alveolar macrophages after inhalation
of high doses of nitric oxide (28). An in vitro study (29) has
shown that PMNs, induced to produce O2
7, and added to
a murine lung cell culture, reduced NO formation.
To conclude, the current study did not yield support for
exhaled NO as a useful marker of ozone-induced oxidative
stress and airway inflammation after a single exposure to
ozone. This contrasts with data for workers chronically
exposed to ozone. The potential for exhaled NO deserves
therefore to be further elucidated.
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